Search results
Kansas Attorney General Kris Kobach sues Pfizer for COVID-19 vaccine
WIBW Topeka· 1 day agoKansas Attorney General Kris Kobach on Monday morning announced he is suing Pfizer for what he said...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 23 hours agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed in state court in ...
Gateway - Quartz
Quartz· 1 hour agoPharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated in 2023 — just as it pulls its COVID-19 vaccines off the shelves. Meanwhile ...
Pfizer Inc. (NYSE:PFE) Position Increased by V Square Quantitative Management LLC
ETF DAILY NEWS· 2 days agoV Square Quantitative Management LLC increased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 260.1% in the 4th quarter, according to the company in its ...
Childress Capital Advisors LLC Has $583,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoChildress Capital Advisors LLC boosted its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.2% during the 4th quarter, according to its most recent 13F filing with the Securities ...
Pfizer Inc. (NYSE:PFE) Shares Sold by Public Employees Retirement System of Ohio
ETF DAILY NEWS· 4 days agoPublic Employees Retirement System of Ohio reduced its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 1.8% during the 4th quarter, HoldingsChannel reports. The ...
Kansas Attorney General sues Pfizer for misleading covid claims
KOAM· 1 day ago(KANSAS) -- Kansas Attorney General Kris Kobach is suing Pfizer for misleading claims made related...
US FDA approves Merck's pneumococcal vaccine for adults
Reuters· 19 hours ago, opens new tab said on Monday the U.S. Food and Drug Administration has approved its...
Merck wins U.S. approval for pneumonia vaccine to rival Pfizer’s
Crain's New York Business· 20 hours agoCapvaxive has the potential to become the preferred vaccine given studies have shown it protects...
Raleigh Capital Management Inc. Sells 2,270 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoRaleigh Capital Management Inc. cut its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure ...
